Skip to main content
Equibles
ATRC logo

ATRC · AtriCure, Inc. · Metrics

Track ATRC — free

Use ATRC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATRC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$57.67 +0.00 (+0.00%) At close · Oct 21
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.95B
Shares
50.87M
Volume · Oct 21 566.36K Avg daily vol (3M) 1.07M

ATRC metrics

95 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$57.67
Market cap
$2.95B

Price action

20 metrics
Price change (1W)
+0.6%
Price change (30D)
-2.0%
Price change (3M)
+72.0%
Price change (6M)
+108.7%
Price change (YTD)
+45.8%
Price change (1Y)
+55.9%
Trailing year
Price change (5Y)
-20.2%
52-week high
$60.77
52-week low
$25.86
Change from 52-week high
-5.1%
Change from 52-week low
+123.0%
Annualized volatility
46.4%
Annualized volatility (3M)
44.2%
Beta
0.6
RSI (14D)
57.5
Price vs SMA 50
+8.0%
Price vs SMA 200
+54.4%
Avg volume (3M)
1.07M
Relative volume
0.5
Average dollar volume
$54.63M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
50.87M

Valuation

12 metrics
P / E (TTM)
274.6
Trailing earnings · reciprocal yield 0.4%
PEG ratio
—
EV / revenue
5.0×
reciprocal yield 20.0%
EV / EBITDA
—
EV / EBIT
220.6×
reciprocal yield 0.5%
P / sales
5.2×
reciprocal yield 19.3%
P / book
5.7
reciprocal yield 17.5%
FCF yield
1.8%
TTM · current market cap
Buyback yield
—
P / FCF
55.6
reciprocal yield 1.8%
P / operating cash flow
45.4
reciprocal yield 2.2%
Earnings yield
0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.2×
reciprocal yield 31.1%
EV / revenue historical average (5Y)
5.5×
reciprocal yield 18.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
74.2×
reciprocal yield 1.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
76.3%
Operating margin
2.3%
Trailing 12 months
Net margin
1.9%
Gross profit (TTM)
$434.61M
Operating profit (TTM)
$12.89M
Net income (TTM)
$10.55M
Trailing 12 months
Diluted EPS (TTM)
$0.21
FCF margin
9.3%
Effective tax rate
12.8%

Per share

11 metrics
Revenue per diluted share (TTM)
$11.75
Gross profit per diluted share (TTM)
$8.97
Operating profit per diluted share (TTM)
$0.26
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.22
Operating cash flow per diluted share (TTM)
$1.35
Free cash flow per diluted share (TTM)
$1.10
Capital expenditures per diluted share (TTM)
$0.24
R&D per diluted share (TTM)
$2.02
Stock compensation per diluted share (TTM)
$0.98
Book value per share
$9.88

Growth

11 metrics
Revenue growth YoY
+12.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$569.62M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.4%
Year over year · more shares
Revenue CAGR (3Y)
+17.4%
Revenue CAGR (5Y)
+20.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.0%
Return on assets
1.6%
Debt / equity
0.1
Current ratio
4.2
EBITDA (TTM)
—
Free cash flow (TTM)
$53.11M
Quick ratio
3.2
Interest coverage
2.3
Net debt / EBITDA
—
Return on invested capital
2.7%
Trailing 12 months
Net cash
$106.79M
Latest balance sheet
Cash & equivalents
$167.79M
Total assets
$676.64M
Total debt
$61.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$64.94M
Capital expenditures (TTM)
$11.82M
R&D (TTM)
$98.03M
SG&A (TTM)
$323.69M
Stock compensation (TTM)
$47.27M
R&D / revenue
17.2%
Stock compensation / revenue
8.3%

Ownership (13F)

9 metrics
13F filers
253
13F filer change QoQ
+29
Institutional ownership
103.4%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+5.5%
Holder tenure
15.3
Price vs estimated holder cost
-11.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.4%

Short interest

3 metrics
Short interest
9.5%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.32M
Insider-sentiment score
12 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1323885 CUSIP 04963C209 13F (30d) 34 filings 34 filers Visit website Investor relations